sur REPLOID Group AG (isin : AT0000A3HRX5)
REPLOID Group AG Acquires Stake in HEROSAN Healthcare GmbH
On October 3, 2025, REPLOID Group AG announced its acquisition of a stake in HEROSAN Healthcare GmbH, marking a strategic move into the sustainable animal feed market. The acquisition is set to occur in two phases, with more than 30% being acquired in 2025, and a complete takeover planned for 2026.
HEROSAN focuses on Europe-wide growth with an emphasis on sustainability in animal nutrition. The company's offerings include feed mixes utilizing hemp and insect protein, functional mushroom components, and select meat products. By acquiring HEROSAN, REPLOID aims to capitalize on the growing demand for premium animal feed products.
This investment seeks to position HEROSAN as a leading feed producer in Europe, expanding REPLOID’s investment portfolio into a high-growth market segment.
R. H.
Copyright © 2025 FinanzWire, tous droits de reproduction et de représentation réservés.
Clause de non responsabilité : bien que puisées aux meilleures sources, les informations et analyses diffusées par FinanzWire sont fournies à titre indicatif et ne constituent en aucune manière une incitation à prendre position sur les marchés financiers.
Cliquez ici pour consulter le communiqué de presse ayant servi de base à la rédaction de cette brève
Voir toutes les actualités de REPLOID Group AG